Dantrolene, a therapeutic agent for malignant hyperthermia, markedly improves the function of failing cardiomyocytes by stabilizing interdomain interactions within the ryanodine receptor.
Dantrolene, a therapeutic agent for malignant hyperthermia, markedly improves the function of failing cardiomyocytes by stabilizing interdomain interactions within the ryanodine receptor.
复制标题
DOI:
10.1016/j.jacc.2009.01.065
复制
发表时间:
2009-05-26
影响因子:
24
通讯作者:
Matsuzaki, Masunori
中科院分区:
文献类型:
--
作者:
Kobayashi, Shigeki;Yano, Masafumi;Suetomi, Takeshi;Ono, Makoto;Tateishi, Hiroki;Mochizuki, Mamoru;Xu, Xiaojuan;Uchinoumi, Hitoshi;Okuda, Shinichi;Yamamoto, Takeshi;Koseki, Noritaka;Kyushiki, Hiroyuki;Ikemoto, Noriaki;Matsuzaki, Masunori
To investigate the effect of dantrolene, a drug generally used to treat Malignant Hyperthermia (MH), on the Ca2+ release and cardiomyocyte function in failing hearts. The N-terminal (N: 1-600) and Central (C: 2000-2500) domains of the ryanodine receptor (RyR), harbor many mutations associated with MH in skeletal muscle RyR (RyR1) and polymorphic ventricular tachycardia in cardiac RyR (RyR2). There is strong evidence that inter-domain interaction between these regions plays an important role in the mechanism of channel regulation. Sarcoplasmic reticulum (SR) vesicles and cardiomyocytes were isolated from dog LV muscles (normal or rapid ventricular pacing for 4 weeks), for Ca2+ leak, transient, and spark assays. To assess the zipped or unzipped state of the interacting domains, the RyR was fluorescently labeled with methylcoumarin acetate in a site-directed manner. We employed a quartz-crystal microbalance technique to identify the dantrolene binding site within the RyR2. Dantrolene specifically bound to domain 601-620 in RyR2. In the SR isolated from pacing-induced dog failing hearts, the defective inter-domain interaction_(domain unzipping) has already occurred, causing spontaneous Ca2+ leak. Dantrolene suppressed both domain unzipping and the Ca2+ leak, showing identical drug concentration-dependence (IC50=0.3 μmol/L). In failing cardiomyocytes, both diastolic Ca2+ sparks and delayed afterdepolarization were frequently observed, but 1 μmol/L dantrolene inhibited both events. Dantrolene corrects defective inter-domain interactions within RyR2 in failing hearts, inhibits spontaneous Ca2+ leak, in turn improves cardiomyocyte function in failing hearts. Thus, dantrolene may have a potential to treat heart failure, specifically targeting the RyR2.
登录
查看更多内容
影响因子:
4.8
作者:
Yamamoto, T;El-Hayek, R;Ikemoto, N
通讯作者:
Ikemoto, N
影响因子:
37.8
作者:
Yano, M;Okuda, S;Matsuzaki, M
通讯作者:
Matsuzaki, M
影响因子:
4.1
作者:
Paul-Pletzer, K;Yamamoto, T;Parness, J
通讯作者:
Parness, J
影响因子:
5
作者:
Meissner, A;Szymanska, G;Morgan, JP
通讯作者:
Morgan, JP
影响因子:
4.8
作者:
Kobayashi, S;Bannister, ML;Ikemoto, N
通讯作者:
Ikemoto, N